The retinoblastoma tumor-suppressor gene, the exception that proves the rule
D W Goodrich
Oncogene 25 ( 38) 5233 -5243
198
2006
Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.
L Connell-Crowley , J W Harper , D W Goodrich
Molecular Biology of the Cell 8 ( 2) 287 -301
355
1997
Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation
A. Van Hooser , D.W. Goodrich , B.R. Brinkley , M.A. Mancini
Journal of Cell Science 111 ( 23) 3497 -3506
261
1998
The molecular genetics of retinoblastoma.
Lee Wh , Goodrich Dw
Cancer surveys 9 ( 3) 529
183
1990
Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
N Arnaiz , D Goodrich , P L Chen , Y M Chen
Oncogene 6 ( 10) 1799 -1805
68
1991
Lineage plasticity in prostate cancer depends on FGFR and JAK/STAT inflammatory signaling
J Chan , S Zaidi , J Love , J Zhao
European Journal of Cancer 174 S4 -S5
2022
Enzalutamide and decitabine in combination inhibits growth of castration resistant prostate cancer cells with a greater response than enzalutamide alone
J Gaddy , D Goodrich , G Chatta , K Wadosky
EUROPEAN JOURNAL OF CANCER 103 E119 -E119
2018
Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
Peter W. T. Pisters , Ming Tan , Raphael E. Pollock , Aiqing Lang
Clinical Cancer Research 4 ( 4) 1065 -1070
20
1998
THE HUMAN RETINOBLASTOMA GENE PRODUCT SUPPRESSES CERAMIDE-INDUCED APOPTOSIS IN HUMAN BLADDER TUMOR CELLS
David J. McConkey , Jim Klostergaard , Cora Bucana , David Goodrich
Oncogene 13 ( 8) 1693 -1700
27
1996
ThoC1 is required for early embryonic development in the mouse
David Goodrich , Xiaoling Wang
Cancer Research 66 596 -597
2006
Theoretical and experimental evidence for hysteresis in cell proliferation.
Shaochun Bai , David Goodrich , C. Dennis Thron , Edwin Tecarro
Cell Cycle 2 ( 1) 46 -52
15
2003
Abstract B13: A novel mouse model for small-cell carcinoma of bladder
Dongbo Xu , Qiang Cao , Li Wang , Yanqing Wang
Cancer Research 80
2020
MP01-10 A NOVEL MOUSE AND ORGANOID MODEL FOR SMALL CELL CARCINOMA OF BLADDER
Dongbo Xu* , Qiang Cao , Li Wang , Yanqing Wang
The Journal of Urology 203
2020
Abstract A033: Identity fraud: Lineage plasticity as a mechanism of antiandrogen resistance and target for therapy
Alastair Davies , Chiara Bostock , Musaddeque Ahmed , Yen-Yi Lin
Cancer Research 78
2018
Effect of Iyengar yoga therapy for chronic low back pain
Kimberly Anne Williams , John Petronis , David Smith , David Goodrich
Pain 115 ( 1) 107 -117
497
2005
Abstract PO-134: Identification of the cells of origin and tumor heterogeneity in neuroendocrine prostate cancer (NEPC) by single-cell analysis
Jimmy L. Zhao , Samir Zaidi , Joseph Chan , Kristine Wadosky
Cancer Research 80
2020
Abstract B32: Transgenic model for early prostate cancer metastasis to the lymph nodes
Hyun-Kyung Ko , Shin AKakura , Jennifer Peresie , David Goodrich
Cancer Research 76
2016
Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma.
Shenmin Yin , David Goodrich
International Journal of Oncology 28 ( 3) 781 -785
5
2006
Pro-Apoptotic Effect of Lenalidomide (L) in Patients with Chronic Lymphocytic Leukemia (CLL) Is Possibly Mediated through Interruption of the Phosphatidylinositol Pathway.
Asher Alban Chanan-Khan , Noreen Ersing , Deborah Krammer , Ralph Bernacki
Blood 108 ( 11) 2102 -2102
8
2006
S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation
Xiaohong Leng , Lisa Connell-Crowley , David Goodrich , J.Wade Harper
Current Biology 7 ( 9) 709 -712
100
1997